Lilin Marsiati, Pristin Prima Sari, R. Kusumawardhani
{"title":"增长机会、资本结构、盈利能力和股利政策对公司价值的影响（2014-2022 年印尼证券交易所上市的制药公司）","authors":"Lilin Marsiati, Pristin Prima Sari, R. Kusumawardhani","doi":"10.36987/ecobi.v11i1.5381","DOIUrl":null,"url":null,"abstract":"This research aims to see the influence of growth opportunities, capital structure, profitability and dividend policy on company value. The type and source of research data is quantitative data using financial reports on pharmaceutical companies listed on the IDX for 2014-2022, while the sampling technique uses purposive sampling to obtain 9 pharmaceutical companies that meet the criteria. The method used in this research is multiple linear regression analysis, using the SPSS program to test it. The results show that partially growth opportunities (PER) and profitability (ROA) have a positive and significant effect on company value. Capital Structure (DER) has a negative but significant effect on company value. Dividend Policy (DPR) has a negative and insignificant effect on company value. Meanwhile, simultaneously the results of the F test and the coefficient of determination test show that X1, X2, X3, and X4 have a simultaneous effect on Y.","PeriodicalId":309702,"journal":{"name":"ECOBISMA (JURNAL EKONOMI, BISNIS DAN MANAJEMEN)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"THE INFLUENCE OF GROWTH OPPORTUNITIES, CAPITAL STRUCTURE, PROFITABILITY, AND DIVIDEND POLICY ON FIRM VALUE (In Pharmaceutical Companies Listed on the Indonesia Stock Exchange 2014-2022)\",\"authors\":\"Lilin Marsiati, Pristin Prima Sari, R. Kusumawardhani\",\"doi\":\"10.36987/ecobi.v11i1.5381\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This research aims to see the influence of growth opportunities, capital structure, profitability and dividend policy on company value. The type and source of research data is quantitative data using financial reports on pharmaceutical companies listed on the IDX for 2014-2022, while the sampling technique uses purposive sampling to obtain 9 pharmaceutical companies that meet the criteria. The method used in this research is multiple linear regression analysis, using the SPSS program to test it. The results show that partially growth opportunities (PER) and profitability (ROA) have a positive and significant effect on company value. Capital Structure (DER) has a negative but significant effect on company value. Dividend Policy (DPR) has a negative and insignificant effect on company value. Meanwhile, simultaneously the results of the F test and the coefficient of determination test show that X1, X2, X3, and X4 have a simultaneous effect on Y.\",\"PeriodicalId\":309702,\"journal\":{\"name\":\"ECOBISMA (JURNAL EKONOMI, BISNIS DAN MANAJEMEN)\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ECOBISMA (JURNAL EKONOMI, BISNIS DAN MANAJEMEN)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36987/ecobi.v11i1.5381\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ECOBISMA (JURNAL EKONOMI, BISNIS DAN MANAJEMEN)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36987/ecobi.v11i1.5381","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
THE INFLUENCE OF GROWTH OPPORTUNITIES, CAPITAL STRUCTURE, PROFITABILITY, AND DIVIDEND POLICY ON FIRM VALUE (In Pharmaceutical Companies Listed on the Indonesia Stock Exchange 2014-2022)
This research aims to see the influence of growth opportunities, capital structure, profitability and dividend policy on company value. The type and source of research data is quantitative data using financial reports on pharmaceutical companies listed on the IDX for 2014-2022, while the sampling technique uses purposive sampling to obtain 9 pharmaceutical companies that meet the criteria. The method used in this research is multiple linear regression analysis, using the SPSS program to test it. The results show that partially growth opportunities (PER) and profitability (ROA) have a positive and significant effect on company value. Capital Structure (DER) has a negative but significant effect on company value. Dividend Policy (DPR) has a negative and insignificant effect on company value. Meanwhile, simultaneously the results of the F test and the coefficient of determination test show that X1, X2, X3, and X4 have a simultaneous effect on Y.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
